Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus: Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection Window

ABSTRACT The time inside the mutant selection window (MSW), TMSW, appears to be less predictive of the selection of fluoroquinolone-resistant Staphylococcus aureus than is the ratio of the area under the concentration-time curve (AUC) to the MIC. This observation might be attributed to the fact that TMSW does not consider the actual position of simulated antibiotic concentrations inside the MSW, which also might influence the amplification of resistant mutants. To test this hypothesis, the enrichment of ciprofloxacin-resistant S. aureus was studied at ciprofloxacin (CIP) concentrations that oscillate near the mutant prevention concentration (MPC), i.e., closer to the top of the MSW (“upper case”), and closer to the MIC, i.e., at the lower limit of the MSW (“lower case”) at the same TMSW. Two methicillin-resistant strains of S. aureus, ATCC 6538 and ATCC 43300 (MICs of 0.25 and 0.5 mg/liter, respectively, and MPCs of 4 and 2 mg/liter, respectively), were exposed to twice-daily CIP treatments for three consecutive days. With S. aureus ATCC 6538, the simulated ratios of the AUC at 24 h (AUC24) to the MIC were 50 and 260 h (TMSW 75% of the dosing interval). With S. aureus ATCC 43300, the simulated AUC24/MICs were 30 and 100 h (TMSW 56%). With each organism, mutants resistant to CIP were enriched in an AUC24/MIC-dependent manner: the higher the AUC24/MIC ratio, the lower the growth on CIP-containing plates. For example, the area under the time-kill curve of mutants resistant to 4× MIC of CIP in the upper case was three times smaller than that in the lower case for both S. aureus strains. Similar differences were seen at the higher (8× MIC) and lower (2× MIC) CIP concentrations. These data highlight differences in the selection of resistant S. aureus, depending on the position of simulated concentrations inside the MSW at a given TMSW. This explains why TMSW-based predictions of resistance are less accurate than those based on AUC/MIC and AUC/MPC.

[1]  C. Destache ANTIMICROBIAL PHARMACODYNAMICS IN THEORY AND CLINICAL PRACTICE, 2ND EDITION , 2008 .

[2]  S. Zinner,et al.  In Vitro Dynamic Models as Tools to Predict Antibiotic Pharmacodynamics , 2007 .

[3]  S. Zinner,et al.  Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model. , 2006, The Journal of antimicrobial chemotherapy.

[4]  O. Cars,et al.  Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration. , 2006, The Journal of antimicrobial chemotherapy.

[5]  P. McNamara,et al.  Evolution of Ciprofloxacin-Resistant Staphylococcus aureus in In Vitro Pharmacokinetic Environments , 2004, Antimicrobial Agents and Chemotherapy.

[6]  A. P. Arzamastsev,et al.  ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model. , 2004, The Journal of antimicrobial chemotherapy.

[7]  S. Zinner,et al.  Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination. , 2004, International journal of antimicrobial agents.

[8]  Xilin Zhao,et al.  Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing. , 2003, The Journal of antimicrobial chemotherapy.

[9]  K. Drlica,et al.  In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.

[10]  K. Bowker,et al.  Mechanism of Fluoroquinolone Resistance Is an Important Factor in Determining the Antimicrobial Effect of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model , 2003, Antimicrobial Agents and Chemotherapy.

[11]  K. Bowker,et al.  Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic Model , 2003, Antimicrobial Agents and Chemotherapy.

[12]  Xilin Zhao,et al.  Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Musser,et al.  Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. , 2000, The Journal of infectious diseases.

[14]  S. Zinner,et al.  Inter- and Intraquinolone Predictors of Antimicrobial Effect in an In Vitro Dynamic Model: New Insight into a Widely Used Concept , 1998, Antimicrobial Agents and Chemotherapy.

[15]  A. Firsov,et al.  Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model , 1997, Antimicrobial agents and chemotherapy.

[16]  Apr Wilson,et al.  Ciprofloxacin: 10 years of clinical experience , 1997 .